Results 151 to 160 of about 9,354,751 (270)

Vasculitis por Propiltiouracilo: reporte de un caso

open access: yesActa Médica Costarricense, 2002
Se reporta el caso clínico de una paciente femenina de 43 años que presentó dos complicaciones secundarias al uso de propiltiouracilo: vasculitis y agranulocitosis.La vasculitis asociada con el tratamiento antitiroideo es una entidad clínica bien ...
Donato A. Salas-Segura   +2 more
doaj  

Outcome measures in ANCA-associated vasculitis.

open access: yes, 2010
The outcome in patients with antineutrophil cytoplasm antibody (ANCA)-associated vasculitis has considerably improved with the use of potent immunosuppression. In the most severe cases, mortality remains an important risk despite aggressive intervention.
Raashid Luqmani   +2 more
core   +1 more source

Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed ‘window of opportunity’

open access: yes, 2020
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of ...
Luca Idolazzi   +13 more
core   +1 more source

ANCA-Associated Vasculitis: Pathogenesis, Models, and Preclinical Testing

open access: yes, 2017
Our understanding of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has developed greatly since the discovery of ANCA, directed against neutrophil components, in 1982.
Stephen R. Holdsworth   +5 more
core   +1 more source

Sequential carbonyl derivatives and hydrazone adduct formation on myeloperoxidase contribute to development of ANCA vasculitis

open access: yesThe Journal of Clinical Investigation
Drug-induced autoimmune diseases are increasingly recognized, although mechanistic insight into disease causation is lacking. Hydralazine exposure has been linked to autoimmune diseases, including antineutrophil cytoplasmic autoantibody (ANCA) vasculitis.
Gang Xi   +12 more
doaj   +1 more source

Extreme thrombocytosis and ANCA-associated vasculitis in an adult patient: a case report

open access: yesBMC Rheumatology
Introduction We describe the case of a 39-year-old woman who presented with extreme reactive thrombocytosis as a prominent and unusual feature in the context of anti-neutrophil cytoplasmic antibody (myeloperoxidase, MPO)-associated vasculitis.
Andrés Hormaza-Jaramillo   +5 more
doaj   +1 more source

Refractory ANCA-associated vasculitis [PDF]

open access: yesRheumatology, 2021
Seerapani Gopaluni   +3 more
openaire   +2 more sources

PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?

open access: yes, 2013
Antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides are rare, but they can be triggered by chemicals, infections and drugs; among them, antithyroid drugs are common.
Bilge, NAZİFE ŞULE   +2 more
core   +1 more source

Predictive utility of ANCA positivity and antigen specificity in the assessment of kidney disease in paediatric-onset small vessel vasculitis

open access: yesRMD Open
Objectives The objective of this study is to evaluate whether anti-neutrophil cytoplasmic antibody (ANCA) seropositivity and antigen specificity at diagnosis have predictive utility in paediatric-onset small vessel vasculitis.Methods Children and ...
Dirk Foell   +26 more
doaj   +1 more source

“Fleshy” Skin Cellulitis: A Triggering Factor for ANCA Associated Vasculitis

open access: yesActa Medica Indonesiana, 2020
A 59-year-old lady with underlying hypothyroidism presented with acute contact dermatitis progressed to cellulitis with superimposed bacterial infection and acute kidney injury.
Sim Chun Yang   +5 more
doaj  

Home - About - Disclaimer - Privacy